Doctors Note Logo

Published on: 7/2/2026

The Doctor-Patient Talk: How to Request a GLP-1 Assessment Successfully

GLP-1 receptor agonists are medications that help manage type 2 diabetes and weight loss by regulating blood sugar and appetite. To prepare for a productive conversation with your doctor, track key health metrics like blood sugar, A1C, and weight, and bring a list of clear questions and treatment goals.

Key factors to discuss include your full medical history, potential side effects, follow-up monitoring plans, and insurance coverage requirements. A focused, data-driven appointment helps ensure the best treatment decision for your needs.

Before your appointment, it's smart to understand your symptoms clearly. Doctors respond better when patients arrive informed and organized, and knowing which symptoms may relate to blood sugar issues, weight concerns, or other conditions can shape a more productive conversation. Take a free, instant, online symptom check to better understand what's going on and confidently navigate your next steps.

Reviewed for medical accuracy: 07/02/2026

answer background

Explanation

The Doctor-Patient Talk: How to Request a GLP-1 Assessment Successfully

GLP-1 receptor agonists (often called "GLP-1s") have emerged as effective tools for managing type 2 diabetes and supporting weight loss. If you're considering these medications, knowing how to talk to a doctor about GLP-1s can make the process smoother. This guide helps you prepare, communicate clearly, and set realistic expectations.


1. Understand GLP-1 Medications

Before you discuss GLP-1s with your doctor, it helps to know:

  • What they are: GLP-1 receptor agonists mimic a natural gut hormone (GLP-1) that regulates blood sugar, slows stomach emptying, and reduces appetite.
  • Common uses: Approved for type 2 diabetes; some are FDA-approved for chronic weight management.
  • Potential benefits:
    • Better blood sugar control
    • Weight loss support
    • Possible cardiovascular benefits
  • Possible side effects: Nausea, vomiting, diarrhea, rare risk of pancreatitis or gallbladder issues.

Armed with this overview, you can have a focused conversation about whether GLP-1s fit your health goals.


2. Track Your Health Metrics

Doctors rely on data. Gather key information before your appointment:

  • Blood sugar readings (if you monitor at home)
  • A1C results (from your latest labs)
  • Weight history (current weight, changes over past months/years)
  • Diet & activity log (notes on what you eat and how active you are)
  • Medication list (all prescriptions, over-the-counter drugs, supplements)
  • Relevant symptoms (hunger, fatigue, digestive issues)

Keep these in a simple journal or spreadsheet. Having numbers and patterns at hand shows you're engaged in your own care.


3. Prepare Your Questions and Goals

Walking into the exam room with clear objectives helps steer the talk. Consider:

  • Your motivation: Better blood sugar control? Weight management?
  • Long-term vision: Preventing diabetes complications, improving quality of life.
  • Key questions:
    • "Based on my A1C and weight trends, am I a candidate for a GLP-1?"
    • "What are the risks and benefits in my specific case?"
    • "How would we monitor progress and side effects?"
    • "What alternatives should I consider if GLP-1 isn't right for me?"

Write these down and bring them to the appointment. It keeps the discussion on track.


4. Initiate the Conversation

Talking about a new medication can feel awkward. Use these communication tips:

  • Be direct but respectful:
    "I've been reading about GLP-1s and wonder if they might help with my blood sugar and weight."
  • Use "I" statements to express your goals:
    "I'd like to reduce my A1C from 8.2% to below 7%."
  • Listen and pause: After your doctor explains, take a moment to digest before responding.
  • Admit uncertainty:
    "I'm not sure if this is an appropriate option for me—can we explore it?"
  • Stay open-minded: If your doctor suggests starting with lifestyle changes or another class of drugs first, ask for the reasoning.

5. Discuss Suitability and Safety

If your doctor thinks GLP-1s might help, they'll assess:

  • Medical history:
    • Pancreatitis or gallbladder disease
    • Personal/family thyroid cancer (some GLP-1s carry a warning)
    • Kidney function
  • Current medications: Interactions with insulin or sulfonylureas may require dose adjustments.
  • Lifestyle factors: Ability to manage side effects, commitment to follow-up.
  • Insurance coverage: Some plans require prior authorization or step therapy.

Ask your doctor to explain how each factor applies to you. Understanding the "why" builds trust and helps you follow the plan.


6. Understand the Assessment Process

If your physician agrees to consider a GLP-1, here's what often follows:

  1. Baseline labs: A1C, kidney and liver function, lipids, sometimes thyroid tests.
  2. Prescription decision: Choice of specific GLP-1 (e.g., semaglutide, liraglutide) based on dosing, side-effect profile, cost.
  3. Insurance authorization: You or your doctor's office may submit documentation to your insurer.
  4. Titration schedule: A low starting dose to minimize nausea, with gradual increases every 2–4 weeks.
  5. Regular check-ins: Office visits or telehealth to monitor weight, A1C, side effects.

Knowing this roadmap in advance helps you feel prepared, not overwhelmed.


7. Plan for Follow-Up and Support

GLP-1s can be powerful, but success relies on consistent follow-up:

  • Set clear checkpoints: Ask, "When should we see each other next?"
  • Monitor side effects: Keep a diary of any nausea or GI discomfort.
  • Lifestyle integration: Confirm that diet and exercise remain central; GLP-1s complement, not replace, healthy habits.
  • Medication costs: Check if patient assistance programs are available.

Bring your journal and questions to every follow-up. Being proactive makes a big difference.


8. If GLP-1s Aren't Right—Next Steps

Your doctor may advise against GLP-1s for valid reasons. If that happens:

  • Ask why: "Can you help me understand the concerns?"
  • Explore alternatives: Other diabetes drugs, more intensive lifestyle or meal-planning interventions, referral to a dietitian or endocrinologist.
  • Get a second opinion: Especially if you feel your concerns weren't fully addressed.
  • Stay engaged: Continue tracking your metrics and report changes or new symptoms.

Remember: You and your doctor share one goal—improving your health safely.


9. Use an Online Symptom Checker for Added Clarity

Before or after your visit, organizing your symptoms and health concerns can strengthen your conversation with your doctor. A free Medically approved AI Symptom Checker Chat Bot can help you:

  • Identify and prioritize which symptoms to discuss at your appointment
  • Generate a clear, concise summary you can share with your healthcare provider
  • Better understand whether your concerns require urgent attention

This preparation tool ensures you walk into your GLP-1 discussion fully prepared and confident.


10. Final Tips for a Productive Visit

  • Arrive early with your prepared notes.
  • Bring a friend or family member for support and a second set of ears.
  • Keep a positive yet realistic attitude: GLP-1s can help, but they require commitment.
  • Ask for written instructions on dosing and follow-up labs.
  • Confirm next steps before you leave: refill process, future appointments, who to call with questions.

By following these steps, you'll be well-equipped to discuss GLP-1 receptor agonists confidently and collaboratively.


When to Seek Immediate Medical Attention

While GLP-1s are generally safe, if you experience any of the following, contact a healthcare professional or emergency services right away:

  • Severe abdominal pain (possible pancreatitis)
  • Signs of an allergic reaction (hives, difficulty breathing)
  • Persistent, uncontrolled vomiting or diarrhea leading to dehydration

Always speak to a doctor about anything that could be life-threatening or serious.


As you prepare to talk to your doctor about GLP-1s, remember: the best outcomes come from shared decision-making, honest communication, and thorough follow-up. Use your data, ask clear questions, weigh benefits and risks together—and keep advocating for your health. Good luck!

(References)

  • * Shaver, H., & Zalesin, K. C. (2023). Shared decision-making for obesity management with GLP-1 receptor agonists: A narrative review. *Journal of Clinical Outcomes Management*, *30*(4), 161-167.

  • * Dykman, R. M., Maeder, S., Mullan, J., & Peiris, D. (2024). Patient perspectives on GLP-1 receptor agonists for weight management: a qualitative study. *BMJ Open*, *14*(4), e082260.

  • * Polle, C. M., Maeder, S., Dykman, R. M., Mullan, J., Peiris, D., & Milat, A. (2024). Navigating conversations about GLP-1 receptor agonists in primary care for obesity. *Obesity Research & Clinical Practice*, *18*(3), 100366.

  • * Hampl, S. E., Kaplan, L. M., & Rubino, D. M. (2023). Facilitating patient-centered care and shared decision-making in obesity management. *Medical Clinics of North America*, *107*(4), 629-640.

  • * Rubino, D. M., & Kaplan, L. M. (2022). Effective Communication in Obesity Management: A Narrative Review. *Obesity (Silver Spring)*, *30*(S2), S11-S17.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.